PASADENA, Calif., April 14, 2015 (GLOBE NEWSWIRE) -- Calhoun Vision, Inc. today announced its participation as an exhibitor in the American Society of Cataract and Refractive Surgery (ASCRS) Symposium & Congress, to be held April 17-21 at the San Diego Convention Center. Attendees will have an opportunity to meet Calhoun Vision’s executive leadership team, including newly appointed Chief Executive Officer Rick Heinick, at Booth #2923 from April 18-20 between 9 a.m. and 5 p.m. PT; company representatives will be available to answer questions regarding the Light Adjustable Lens technology.
Calhoun Vision will also be sponsoring a Light Adjustable Lens (LAL) Symposium as part of the EyeWorld Corporate Mornings program. The details are as follows:
Date: Saturday, April 18, 2015
Time: 8:00 a.m. PT
Location: San Diego Convention Center, Room 7B
Program Chair: Robert Maloney, MD
Faculty:
- David F. Chang, MD
- William Wiley, MD
- John Doane, MD
- Vance Thompson, MD
Topics: Clinical Benefits of Refractive Accuracy, Overcoming Biometry Errors, Range of Capabilities, Transforming Refractive Cataract Practice, and Visual and Refractive Results with the LAL.
Additional information for the symposium can be accessed at http://www.eyeworld.org/meetings/go?1.page_num=1&1.page_size=10&page=Home&10.2.4.view.item=170. Online pre-registration is over, but guests may still attend the event without pre-registering.
Attendees are also encouraged to join sessions on advanced IOL technologies at ASCRS including presentations on Light Adjustable Lens technology.
“We look forward to sharing our novel LAL technology at ASCRS,” said Mr. Heinick. “This is an exciting time for our company, as we recently completed enrollment of our 600-patient Phase III clinical trial of the LAL. We are confident in our technology’s ability to address unmet needs in cataract surgery through its unparalleled customization for each patient.”
About Calhoun Vision
Calhoun Vision, Inc. is a privately held company that is redefining lens implant surgery by developing intraocular lenses that, when combined with a custom-designed digital light source, enable surgeons to change the power of a lens after it has been implanted. This offers the potential to provide superb visual outcomes and customization to the specific visual needs of each patient. Calhoun Vision’s Light Adjustable Lens (LAL®) is CE Mark approved in Europe, and is commercially available in Germany, the United Kingdom, France, Italy, Spain, Mexico and the Czech Republic. The LAL is currently in a pivotal Phase III clinical trial for the treatment of spherocylindrical refractive errors in the U.S.
Disclaimer: The Light Adjustable Lens (LAL) is an investigational device and is not approved for sale within the U.S. Limited by Federal law to investigational use.
CONTACT: INVESTOR CONTACT Alex Huang Calhoun Vision 626-219-1475 ahuang@calhounvision.com MEDIA CONTACT Laura Bagby 6 Degrees 312-448-8098 lbagby@6degreespr.com
Help employers find you! Check out all the jobs and post your resume.
